S

Surrozen
D

SRZN

29.930
USD
1.88
(6.70%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-1
حجم السوق
343,797,141
المقالات
المزيد

العنوان: Surrozen

القطاع: Healthcare
الصناعة: Biotechnology
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).